Wednesday, 22 October 2008 15:00–16:00PLENARY SESSION 2Proffered paper session34 ORAL Advantages of a modified continual reassessment method (CRM) for dose finding studies: experience in ongoing phase I trials with ABT-263
PLENARY SESSION 2
Proffered paper session
References (0)
Cited by (0)
Copyright © 2008 Elsevier Ltd. All rights reserved.